BioPharm International's BP Elements, April 2023

Stability and in vivo performance aren't just affected by lipids.

Lives are saved when time from vein to vein decreases.

Lonza and ABL Bio are collaborating on the development and manufacture of bispecific antibody product.

Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel.

Moderna and Generation Bio have announced a strategic collaboration to develop non-viral genetic medicines.

Under a new partnership, Invitae and Deerfield Management will harness genetic and clinical testing data from patients to discover potential novel therapeutics for treating rare diseases.

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.

Evotec and Bristol Myers Squibb have announced progress in their strategic protein degradation partnership.

Predictive Oncology and Cancer Research Horizons have partnered to pursue development of cancer drugs utilizing the PEDAL platform.

The collaboration between Genuv and Celltrion will utilize Genuv's proprietary mouse platform for antibody discovery.